CoChat

Weizmannia coagulans BC99 alleviates hyperuricemia and oxidative stress via DAF-16/SKN-1 activation in Caenorhabditis elegan

Open access
Gao, Yinyin, Li, Cheng, Li, Junfei, Duan, Mengyao, Li, Xuan, Zhao, Lina, Wu, Ying, Gu, Shaobin · 2024 · Frontiers in Microbiology

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Introduction: Hyperuricemia (HUA) refers to the presence of excess uric acid (UA) in the blood, which increases the risk of chronic kidney disease and gout. Probiotics have the potential to alleviate HUA. Methods: This study established a hyperuricemia model using Caenorhabditis elegans (C. elegans), and studied the anti-hyperuricemia activity and potential mechanisms of Weizmannella coagulans BC99 (W. coagulans) at different concentrations (10 7 CFU/mL BC99, 10 8 CFU/mL BC99). Subsequently, we utilized UPLC-Q-TOF/MS to investigate the impact of BC99 on endogenous metabolites in C. elegans and identified pathways and biomarkers through differential metabolomics analysis. Results: The results of this study showed that BC99 treatment significantly reduced the expression of P151.2 and T22F3.3 (p < 0.05), reduced the levels of UA and xanthine oxidase (XOD) in nematodes (p < 0.05), while extending their lifespan and movement ability (p < 0.05). Mechanistically, BC99 activates the transcription factors DAF-16 and SKN-1, thereby inducing the expression of stress response genes, enhancing the activity of antioxidant enzymes and tolerance to heat stress in the body, and reducing the production of ROS (p < 0.001). This effect was most significant in the H-BC99 group. Furthermore, non-targeted metabolomics indicated that BC99 predominantly regulated pathways associated with amino acid metabolism (Carnosine), glycerophospholipid metabolism, and purine metabolism. Discussion: These results underscore BC99 as an effective and economical adjunct therapeutic agent for hyperuricemia, providing a scientific basis for further development and application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2024.1498540

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Effect of Weizmannella coagulans BC99 on high uric acid model in C. elegans. (A) UA; (B) XOD; (C) lifespan; (D) average lifespan; (E) haed swing; (F) body bending. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Data are presented as the mean ± SD. Compared with CON group, significant differences in the MOD group are represented by #, #p < 0.05, ##p < 0.01, ###p < 0.001. Compared with the MOD group, significant differences in the BC99 group are represented by *, *p < 0.05, **p < 0.01, ***p < 0.001.
FIGURE 1 Effect of Weizmannella coagulans BC99 on high uric acid model in C. elegans. (A) UA; (B) XOD; (C) lifespan; (D) average lifespan; (E) haed swing; (F) body bending. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Data are presented as the mean ± SD. Compared with CON group, significant differences in the MOD group are represented by #, #p < 0.05, ##p < 0.01, ###p < 0.001. Compared with the MOD group, significant differences in the BC99 group are represented by *, *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central
FIGURE 2 Weizmannella coagulans. W. coagulans BC99 enhances the resistance of C. elegans to stress conditions (n = 10). (A) Image of ROS expression in C. elegans; (B) quantitative fluorescence analysis of worms. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with the CON group, ###p < 0.001. Compared with the MOD group, ***p < 0.001.
FIGURE 2 Weizmannella coagulans. W. coagulans BC99 enhances the resistance of C. elegans to stress conditions (n = 10). (A) Image of ROS expression in C. elegans; (B) quantitative fluorescence analysis of worms. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with the CON group, ###p < 0.001. Compared with the MOD group, ***p < 0.001.CC BY · PubMed Central
FIGURE 3 Effects of T W. coagulans on the antioxidant capacity of a hyperuricemic nematode model. (A) SOD; (B) GSH; (C) CAT; (D) MDA. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with the CON group, ###p < 0.001. Compared with the MOD group, ***p < 0.001.
FIGURE 3 Effects of T W. coagulans on the antioxidant capacity of a hyperuricemic nematode model. (A) SOD; (B) GSH; (C) CAT; (D) MDA. L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with the CON group, ###p < 0.001. Compared with the MOD group, ***p < 0.001.CC BY · PubMed Central
FIGURE 4 W. coagulans the resistance of C. elegans to stress conditions and regulates related genes. (A) Y105E.8; (B) R151.2; (C) T22F3.3; (D) skn-1; (E) IIS (daf-2, daf-16, ctl-2 and sod-3). (F,G) Survival of DAF-2 (CB1370) under heat stress; (H,I) survival of DAF-16 (GR1307) under heat stress; (J,K) survival of SKN-1 (GR2245) under heat stress). L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with CON group, significant differences in the MOD group are represented by #, #p < 0.05, ##p < 0.01, ###p < 0.001. Compared with the MOD group, significant differences in the BC99 group are represented by *, *p < 0.05, **p < 0.01, ***p < 0.001.
FIGURE 4 W. coagulans the resistance of C. elegans to stress conditions and regulates related genes. (A) Y105E.8; (B) R151.2; (C) T22F3.3; (D) skn-1; (E) IIS (daf-2, daf-16, ctl-2 and sod-3). (F,G) Survival of DAF-2 (CB1370) under heat stress; (H,I) survival of DAF-16 (GR1307) under heat stress; (J,K) survival of SKN-1 (GR2245) under heat stress). L-BC99 represents the low-dose BC99 treatment group (107 CFU/mL), while H-BC99 represents the high-dose BC99 treatment group (108 CFU/mL). Compared with CON group, significant differences in the MOD group are represented by #, #p < 0.05, ##p < 0.01, ###p < 0.001. Compared with the MOD group, significant differences in the BC99 group are represented by *, *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central
FIGURE 5 Serum metabolic profiling. (A) CON and MOD groups in ESI+ and ESI− mode; (B) MOD and BC99 groups in ESI+ and ESI− mode; (C) PCA score diagram of the CON group and MOD group in ESI+ mode and ESI− mode; (D) PCA score diagram of the MOD group and BC99 group in ESI+ mode and ESI− mode; (E) OPLS-DA score diagram of the CON group and MOD group in ESI+ mode and ESI− mode; (F) OPLS-DA score diagram of the MOD group and BC99 group in ESI+ mode and ESI− mode.
FIGURE 5 Serum metabolic profiling. (A) CON and MOD groups in ESI+ and ESI− mode; (B) MOD and BC99 groups in ESI+ and ESI− mode; (C) PCA score diagram of the CON group and MOD group in ESI+ mode and ESI− mode; (D) PCA score diagram of the MOD group and BC99 group in ESI+ mode and ESI− mode; (E) OPLS-DA score diagram of the CON group and MOD group in ESI+ mode and ESI− mode; (F) OPLS-DA score diagram of the MOD group and BC99 group in ESI+ mode and ESI− mode.CC BY · PubMed Central
FIGURE 6 Effect of BC99 on differential metabolites in C. elegans. (A) Heatmap showing metabolites among different groups; (B) volcano plot (CON/MOD); (C) volcano plot (MOD/BC99); (D) matchstick plot analysis of differential metabolites (CON/MOD); (E) matchstick plot analysis of differential metabolites (MOD/BC99); (F) correlations between biochemical markers and metabolites. Red indicates positive correlation and blue indicates negative correlation.
FIGURE 6 Effect of BC99 on differential metabolites in C. elegans. (A) Heatmap showing metabolites among different groups; (B) volcano plot (CON/MOD); (C) volcano plot (MOD/BC99); (D) matchstick plot analysis of differential metabolites (CON/MOD); (E) matchstick plot analysis of differential metabolites (MOD/BC99); (F) correlations between biochemical markers and metabolites. Red indicates positive correlation and blue indicates negative correlation.CC BY · PubMed Central
FIGURE 7 Pathway analysis of significantly altered metabolites. (A) KEGG classification diagram of differential metabolites in different groups; (B) KEGG enrichment map of differential metabolites in different groups. The abscissa represents the RichFactor corresponding to each pathway, and the ordinate represents the name of the KEGG metabolic pathway. The size of the dots represents the number of differential metabolites enriched in the pathway. The color indicates the size of the p-value. The smaller the p-value, the redder the color, indicating the more significant the degree of enrichment.
FIGURE 7 Pathway analysis of significantly altered metabolites. (A) KEGG classification diagram of differential metabolites in different groups; (B) KEGG enrichment map of differential metabolites in different groups. The abscissa represents the RichFactor corresponding to each pathway, and the ordinate represents the name of the KEGG metabolic pathway. The size of the dots represents the number of differential metabolites enriched in the pathway. The color indicates the size of the p-value. The smaller the p-value, the redder the color, indicating the more significant the degree of enrichment.CC BY · PubMed Central
FIGURE 8 Intervention of W. coagulans on the metabolism of MOD mice. The black arrows represent the trend of metabolite changes in MOD mice and the green arrows represent the trend of metabolite shift after BC99 intervention.
FIGURE 8 Intervention of W. coagulans on the metabolism of MOD mice. The black arrows represent the trend of metabolite changes in MOD mice and the green arrows represent the trend of metabolite shift after BC99 intervention.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 53 references

Research works printed but not linked: 2

  1. Yin, 2024, Toxic Effect and molecular mechanism of arsenolipids on promoting aging of Caenorhabditis elegans., Food Sci., 45, 131
  2. Ying, 2021, Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid., Gut microbes, 13, 1, 10.1080/19490976.2021.1897211 · DOI · Paper page

Cited by

See all 9

Metadata

Authors
Gao, Y., Li, C., Li, J., Duan, M., Li, X., Zhao, L., Wu, Y., & Gu, S.
Affiliations
Henan University of Science and Technology (CN)
Corresponding author
  • Wu, Ying
  • Gu, Shaobin
Venue
Frontiers in Microbiology
Published
2024-12-11
Volume
15
Pages
1498540-1498540
ISSN
1664-302X (ISSN-L)
OpenAlex
W4405257877
Cited by
9
References
53
Citations by year
2026: 4 · 2025: 5
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (32302069)
Topics
  • Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
hyperuricemia, uric acid, oxidative stress, DAF-16, SKN-1, Caenorhabditis elegans, probiotics, xanthine oxidase, purine metabolism, carnosine, glycerophospholipid metabolism, amino acid metabolism, lifespan extension, heat tolerance, antioxidant enzymes, reactive oxygen species, metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weizmannia coagulans BC99 alleviates hyperuricemia and oxidative stress via DAF-16/SKN-1 activation in Caenorhabditis elegan. https://app.cochat.ai/papers/10.3389/fmicb.2024.1498540
The paper
Gao, Y., Li, C., Li, J., Duan, M., Li, X., Zhao, L., Wu, Y., & Gu, S. (2024). Weizmannia coagulans BC99 alleviates hyperuricemia and oxidative stress via DAF-16/SKN-1 activation in Caenorhabditis elegan. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2024.1498540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.